Clinical Comparison of Renogen, a Biosimilar Epoetin-a, with the Originator, Eprex, in Chronic Kidney Disease Anemia in Indonesia: A Preliminary Study

Clinical Comparison of Renogen, a Biosimilar Epoetin-a, with the Originator, Eprex, in Chronic Kidney Disease Anemia in Indonesia: A Preliminary Study

Background: treatment of erythropoietin (EPO) is essential in chronic kidney disease (CKD) patients to maintain optimal hemoglobin (Hb) level. Renogen is a biosimilar epoetin-α, and Eprex is the originator epoetin-α. This study aimed to compare the efficacy and tolerance of Renogen with Eprex in CKD...

Full description

Bibliographic Details
Main Authors: Ni Made Hustrini, Parlindungan Siregar, Arini Setiawati, Pringgodigdo Nugroho
Format: Article
Language:English
Published: Interna Publishing 2019-11-01
Series:Acta Medica Indonesiana
Subjects:
renal anemia
erythropoietin
biosimilar
hemodialysis
Online Access:http://actamedindones.org/index.php/ijim/article/view/1053

Internet

http://actamedindones.org/index.php/ijim/article/view/1053

Similar Items